Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pegfilgrastim vs filgrastim in pediatric patients with hematologic malignancies
2007-001430-14Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Jan 2008
- Modality
- Recombinant Proteins and Enzymes, Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of pegfilgrastim and filgrastim in hematopoietic malignancies (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoint: Time to recovery of myeloid cells. Started Jan 2008; status: active.
02
Drugs
pegfilgrastimfilgrastim
03
Conditions
hematopoietic malignancies
Beyond the preview
Go deeper on 2007-001430-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001430-14.